Literature DB >> 9834373

Selective management of hepatic venous outflow obstruction.

G G Tsiotos1, D M Nagorney.   

Abstract

To describe the outcome of selective management of hepatic venous outflow obstruction (HVOO), based on its presentation and liver function, we reviewed the records of 49 consecutive patients managed at our institution between 1984 and 1993. Twenty-six patients were managed surgically, 12 nonsurgically, and 11 were not treated. Portosystemic shunts (PSS) were performed in 18 patients (patency 83%). Two patients (11%) died postoperatively, 11 (61%) did well (mean follow-up 6.4 years), three (17%) required subsequent orthotopic liver transplantation, and two (11%) died of late liver failure. PSS remained patent if the preoperative pressure gradient between the portal vein and the infrahepatic inferior vena cava was greater than 10 mm Hg and across the intrahepatic inferior vena cava 18 mm Hg or less. All six orthotopic liver transplantations (three as primary treatment and three after failed PSS) were successful (mean follow-up 4.8 years). Five patients underwent other procedures. Nine (75%) of the 12 nonsurgically treated patients did well (mean follow-up 3.8 years). The most important predictor of successful outcome after PSS or medical management was the degree of liver function. All 11 untreated patients died either of end-stage liver failure (n = 7; 63%) or of severe comorbid disease (n = 4; 37%). In patients with preserved liver function, medical management of HVOO can be successful early in the course of the disease; a late presentation necessitates PSS. Orthotopic liver transplantation should be employed in patients with liver failure and may decrease the high mortality rate of HVOO.

Entities:  

Mesh:

Year:  1997        PMID: 9834373     DOI: 10.1016/s1091-255x(97)80060-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  33 in total

1.  Long term results of treatment of Budd-Chiari syndrome by side to side portacaval shunt.

Authors:  M J Orloff; B Girard
Journal:  Surg Gynecol Obstet       Date:  1989-01

2.  Approach to the spectrum of Budd-Chiari syndrome: which patients require portal decompression?

Authors:  W J Millikan; J M Henderson; C W Sewell; R A Guyton; J R Potts; C A Cranford; A R Cramer; J T Galambos; W D Warren
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

3.  Budd-Chiari syndrome with extensive portal thrombosis: treatment with Senning's procedure.

Authors:  A Sauvanet; Y Panis; D Valla; V Vilgrain; J Belghiti
Journal:  Hepatogastroenterology       Date:  1994-04

4.  Management of hepatic venous outflow obstruction.

Authors:  V Kohli; G K Pande; V Dev; K S Reddy; U Kaul; S Nundy
Journal:  Lancet       Date:  1993-09-18       Impact factor: 79.321

Review 5.  Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature.

Authors:  J B Dilawari; P Bambery; Y Chawla; U Kaur; S R Bhusnurmath; H S Malhotra; G K Sood; S K Mitra; S K Khanna; B S Walia
Journal:  Medicine (Baltimore)       Date:  1994-01       Impact factor: 1.889

6.  Simultaneous retrohepatic inferior vena cavoplasty and side-to-side portacaval shunt for recurrent thrombosed mesoatrial shunt in the Budd-Chiari syndrome.

Authors:  S S Ahn; L I Goldstein; R W Busuttil
Journal:  Surgery       Date:  1987-02       Impact factor: 3.982

7.  Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome after failure of surgical shunting.

Authors:  A Rogopoulos; A Gavelli; H Sakai; M McNamara; C Huguet
Journal:  Arch Surg       Date:  1995-02

8.  Expandable venous stents for treatment of the Budd-Chiari syndrome.

Authors:  R R Lopez; K G Benner; L Hall; J Rösch; C W Pinson
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

9.  Budd-Chiari syndrome: early intervention with angioplasty and thrombolytic therapy.

Authors:  J W Frank; P S Kamath; A W Stanson
Journal:  Mayo Clin Proc       Date:  1994-09       Impact factor: 7.616

10.  Results of portal systemic shunts in Budd-Chiari syndrome.

Authors:  C Vons; C Smadja; E Bourstyn; A M Szekely; P Bonnet; D Franco
Journal:  Ann Surg       Date:  1986-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.